Literature DB >> 22845719

Routine use of a rapid test to detect bacteria at the time of issue for nonleukoreduced, whole blood-derived platelets.

Sarah K Harm1, Meghan Delaney, Michael Charapata, James P Aubuchon, Darrell J Triulzi, Mark H Yazer.   

Abstract

BACKGROUND: The Pan Genera detection (PGD) test is used to screen platelet (PLT) products for bacterial contamination. We report the experience of using the PGD test on whole blood-derived PLTs (WBPs) at two large centralized transfusion services (CTS). STUDY DESIGN AND METHODS: Records of PGD test results were retrospectively reviewed. The PGD test was performed on individual WBP units or pools of WBPs ranging in size from 2 to 6 units at the time of issue. Bacterial culture was performed on PLT products with positive PGD tests, and at one CTS, the available cocomponents.
RESULTS: A total of 70,561 WBP pools were screened with the PGD test. There were seven true-positive PGD tests and 242 false-positive tests (positive predictive value of PGD test, 2.81%). The overall contamination rate was 99 per 10(6) WBP pools (1:10,080; 95% confidence interval [CI], 40-204), and the false-positive rate was 3430 per 10(6) WBP pools (1:292; 95% CI, 3011-3890). All seven bacterial isolates were Gram positive. The median age of the individual WBP units in the seven contaminated pools was 5 days (range, 3-5 days) compared to 4 days (range, 1-5 days) in the false-positive pools (p=0.0012). The same bacteria isolated from a positive PLT pool also grew in one red blood cell cocomponent.
CONCLUSION: After testing more than 70,000 WBP pools at two large CTSs, the rate of contaminated WBP pools detected by the PGD test was 99 per 10(6) pools (1:10,080).
© 2012 American Association of Blood Banks.

Mesh:

Year:  2012        PMID: 22845719     DOI: 10.1111/j.1537-2995.2012.03818.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Diagnostic methods for platelet bacteria screening: current status and developments.

Authors:  Melanie Störmer; Tanja Vollmer
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

2.  Bacterial screening of platelet concentrates on day 2 and 3 with flow cytometry: the optimal sampling time point?

Authors:  Tanja Vollmer; Volkmar Schottstedt; Juergen Bux; Gabriele Walther-Wenke; Cornelius Knabbe; Jens Dreier
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

3.  Bench Test for the Detection of Bacterial Contamination in Platelet Concentrates Using Rapid and Cultural Detection Methods with a Standardized Proficiency Panel.

Authors:  Tanja Vollmer; Cornelius Knabbe; Wolf-Jochen Geilenkeuser; Michael Schmidt; Jens Dreier
Journal:  Transfus Med Hemother       Date:  2015-07-16       Impact factor: 3.747

4.  Molecular detection of bacterial contamination in plasma using magnetic-based enrichment.

Authors:  Jinyeop Lee; Abdurhaman Teyib Abafogi; Sujin Oh; Ho Eun Chang; Wu Tepeng; Daekyu Lee; Sungsu Park; Kyoung Un Park; Yun Ji Hong
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

5.  Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.

Authors:  Heather F Pidcoke; Steve J McFaul; Anand K Ramasubramanian; Bijaya K Parida; Alex G Mora; Chriselda G Fedyk; Krystal K Valdez-Delgado; Robbie K Montgomery; Kristin M Reddoch; Armando C Rodriguez; James K Aden; John A Jones; Ron S Bryant; Michael R Scherer; Heather L Reddy; Raymond P Goodrich; Andrew P Cap
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

Review 6.  Recent Advances in Preventing Adverse Reactions to Transfusion.

Authors:  Thomas S Rogers; Mark K Fung; Sarah K Harm
Journal:  F1000Res       Date:  2015-12-17

7.  Cost implications of implementation of pathogen-inactivated platelets.

Authors:  Jeffrey McCullough; Dennis Goldfinger; Jed Gorlin; William J Riley; Harpreet Sandhu; Christopher Stowell; Dawn Ward; Mary Clay; Shelley Pulkrabek; Vera Chrebtow; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-05-18       Impact factor: 3.157

8.  Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.

Authors:  Steve Kleinman; Adonis Stassinopoulos
Journal:  Transfusion       Date:  2015-08-25       Impact factor: 3.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.